- ODX Platform
- ODX Analytics
- User Resources
- Why ODX?
Welcome to part 9 of the ODX Andropause & Low T Syndrome Series. In this final post in our series, we cover the Optimal Takeaways for the assessment and treatment of Andropause or Low T Syndrome
Assessment and treatment of late onset hypogonadism should be a priority for men’s health because of its close association with morbidity and mortality. It can interfere with function and quality of life and should be addressed as early as possible. LOH is most often associated with older age, obesity, co-morbidities, and general poor health.
[i] Karakas, Sidika E, and Prasanth Surampudi. “New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men.” Advances in clinical chemistry vol. 86 (2018): 71-125. doi:10.1016/bs.acc.2018.06.001 [R]